SAFC Converts Facility to Animal Component Free Status - - BioPharm International

ADVERTISEMENT

SAFC Converts Facility to Animal Component Free Status

BioPharm Bulletin

SAFC Biosciences (Lenexa, KS) has completed the conversion of its dry powder cell culture media continuous milling production site in Lenexa, KS to animal component free (ACF) status. This is the first of several similar conversions planned by SAFC Biosciences to support growing customer requirements for ACF manufacturing.

During this facility’s ACF conversion, an extensive cleaning conversion protocol was completed and systems and procedures were reviewed and modified. This process addressed several comprehensive factors, including:

• Cleaning protocol and documentation
• facility analysis of air, personnel, equipment, and process flows
• raw material procedures—from receipt, inspection, sampling, quarantine, and storage to release
• standard operating procedures review against ACF requirements, with changes implemented to cover product sampling, personnel and product flows, and cleaning
• personnel training records review and pertinent training updates before ACF conversion
• risk analysis performed on all equipment and components used in ACF areas
• ACF status and manufacturing information collected on all raw materials
• contamination remediation plan instituted for any system breech, including provisions for equipment decontamination, cleaning procedures, personnel and process flows, timelines and business continuity planning.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines
Source: BioPharm Bulletin,
Click here